Neuromersiv
Sydney
About Neuromersiv
Neuromersiv is a Sydney-based digital health company with the aim of treating chronic neurological conditions using immersive virtual reality (VR). Neuromersiv's first product, Ulysses™ is a clinically designed, Australian TGA and UK MHRA-approved VR-based upper-limb therapy system that empowers stroke, spinal cord, and acquired brain injury survivors by helping them regain lost independence and quality of life. Ulysses enhances rehabilitation through clinically validated, task-specific training in immersive VR to maximise engagement, compliance, and functional recovery.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $1.1M
- Funding stage: Seed
- Last round: Grant (Jun 2024)
- Website: neuromersiv.com
- Phone: +61415142313
Industries & Categories
Electronics, Health Care, Software
Social Profiles
Canonical: https://fsome.com/organization/neuromersiv-163762 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.